UNBELIEVABLE: Johnson johnson | History Defined

AstraZeneca vs. Johnson & Johnson: Which Drug Manufacturer is a Better Buy?

The COVID-19 pandemic has boosted the revenues of most drug manufacturers. And since healthcare expenditure has been climbing steadily, and because the global population is aging, the demand for medicines is expected to grow. Quality drug manufacturers AstraZeneca (AZN) and Johnson & Johnson (JNJ) should benefit from this trend. But…

StockNews.com · Mar 17, 2022

This Day In Market History: Walmart, Johnson & Johnson Join Dow Jones Industrial Average

Each day, Benzinga takes a look back at a notable market-related moment that occurred on this date.

Benzinga · Mar 17, 2022

Where Johnson & Johnson Stands With Analysts

Over the past 3 months, 4 analysts have published their opinion on Johnson & Johnson (NYSE:JNJ) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga · Mar 16, 2022

Benzinga Bulls And Bears Of The Past Week: Shopify, Palantir, Apple, Meta, Twitter, Johnson & Johnson, American Express And More

Benzinga has examined the prospects for many investor favorite stocks over the past week.

Benzinga · Mar 5, 2022

To be 1 in a million: ‘Who thinks it’s going to be you?’

BEND, Ore. — Monica Melkonian wanted the Johnson & Johnson COVID-19 vaccine. It was only one shot and then she would be protected against the virus. So she was thrilled when the vaccination clinic at the Deschutes County Fair & Expo Center on April 7 had her first choice.

Tribune News Service · Mar 4, 2022

Johnson & Johnson's COVID-19 Vaccine Less Effective Against Hospitalization, French Study Shows

According to a large French study, the risk of hospitalization after vaccination with Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine was about five times higher than those who received the Pfizer Inc (NYSE:

Benzinga · Mar 3, 2022

This Is What Whales Are Betting On Johnson & Johnson

Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga · Feb 28, 2022

Johnson & Johnson Allowed To Move Ahead With Bankruptcy Strategy On Talc Lawsuits: WSJ

In a federal bankruptcy court in Trenton, New Jersey, Judge Michael Kaplan ruled in favor of Johnson & Johnson's (NYSE: JNJ) controversial bankruptcy filing meant to settle 38,000 claims alleging its talc-based products caused cancer.

Benzinga · Feb 28, 2022

Johnson & Johnson Sees A Strong Move: Is It Ready For A Breakout?

Johnson & Johnson (NYSE: JNJ) shares are trading higher Friday after the company agreed to finalize a proposed $26 billion settlement resolving more than 3,000 lawsuits, mainly by state and local governments, seeking to hold it and three other companies responsible for th

Benzinga · Feb 25, 2022

Does CBD Have To Be Water Soluble? One Group Of Scientists Say Yes For Better Absorption

Several former scientists and staff from companies like Johnson & Johnson (NYSE: JNJ), GlaxoSmithKline (NYSE: GSK) and Schiff Nutrition are bringing a new delivery platform to market that boosts the bioavailability of&

Benzinga · Feb 25, 2022